These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9148243)

  • 1. Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum.
    Shishido T; Watanabe Y; Suzuki H; Kato K; Niwa S; Hanoune J; Matsuoka I
    Neurosci Lett; 1997 Feb; 222(3):175-8. PubMed ID: 9148243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
    Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
    J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine.
    Wang JQ; McGinty JF
    Synapse; 1996 Feb; 22(2):114-22. PubMed ID: 8787127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.
    Chen JF; Aloyo VJ; Qin ZH; Weiss B
    Neurochem Int; 1994 Oct; 25(4):355-66. PubMed ID: 7820070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles of dopamine D1 and D2 receptor-containing neurons of the nucleus accumbens shell in behavioral sensitization.
    Kai N; Nishizawa K; Tsutsui Y; Ueda S; Kobayashi K
    J Neurochem; 2015 Dec; 135(6):1232-41. PubMed ID: 26442961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
    Landa L; Jurajda M; Sulcova A
    Neuro Endocrinol Lett; 2012; 33(4):446-52. PubMed ID: 22936253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.
    Hamamura T; Akiyama K; Akimoto K; Kashihara K; Okumura K; Ujike H; Otsuki S
    Brain Res; 1991 Apr; 546(1):40-6. PubMed ID: 1677305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemogenetic Inhibition of Dopamine D1-expressing Neurons in the Dorsal Striatum does not alter Methamphetamine Intake in either Male or Female Long Evans Rats.
    Job MO; Chojnacki MR; Daiwile AP; Cadet JL
    Neurosci Lett; 2020 Jun; 729():134987. PubMed ID: 32371155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum.
    Chen JF; Weiss B
    Brain Res Dev Brain Res; 1991 Nov; 63(1-2):95-104. PubMed ID: 1665109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain.
    Angulo JA
    J Neurochem; 1992 Mar; 58(3):1104-9. PubMed ID: 1346626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain.
    Wang JQ; McGinty JF
    J Neurochem; 1995 Dec; 65(6):2706-15. PubMed ID: 7595569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum.
    Rappaport MS; Sealfon SC; Prikhozhan A; Huntley GW; Morrison JH
    Brain Res; 1993 Jul; 616(1-2):242-50. PubMed ID: 8358616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants.
    Corvol JC; Valjent E; Pascoli V; Robin A; Stipanovich A; Luedtke RR; Belluscio L; Girault JA; Hervé D
    Neuropsychopharmacology; 2007 May; 32(5):1109-21. PubMed ID: 17063155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells.
    de Gortari P; Mengod G
    Brain Res; 2010 Jan; 1310():37-45. PubMed ID: 19913519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.
    Perreault ML; Graham D; Scattolon S; Wang Y; Szechtman H; Foster JA
    Psychopharmacology (Berl); 2007 Nov; 194(4):485-96. PubMed ID: 17619861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated reserpine increases striatal dopamine receptor and guanine nucleotide binding protein RNA.
    Butkerait P; Friedman E
    J Neurochem; 1993 Feb; 60(2):566-71. PubMed ID: 8419537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of D1 and D2 dopamine receptors and associated second messenger systems in fetal striatal transplants.
    Helm GA; Robertson MW; Jallo GI; Simmons N; Bennett JP
    Exp Neurol; 1991 Feb; 111(2):181-9. PubMed ID: 1703498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity.
    Schettini G; Ventra C; Florio T; Grimaldi M; Meucci O; Marino A
    J Neurochem; 1992 Nov; 59(5):1667-74. PubMed ID: 1402912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.